Overview
- Editors:
-
-
Kelly L. Stratton
-
Urology, University of Oklahoma Health Science Center, Oklahoma City, USA
-
Alicia K. Morgans
-
Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
- Illuminates the benefits of multidisciplinary co-management
- Emphasizes the upcoming expansion of new therapeutics for urologic malignancies
- Written by leading experts in the practice of team-based urological care
About this book
Urologists and medical oncologists have witnessed a rapid growth in systemic therapeutic options for treating genitourinary malignancies that increasingly integrates radiation therapy to primary cancers, nodal beds, and even metastatic sites. The culmination of these advances has been the creation of multidisciplinary teams that expertly provide comprehensive care to patients with urologic cancers. This book provides the framework to create such a multidisciplinary clinical team focused on the treatment of urologic malignancies with representation from urologists, medical oncologists, and additional specialists who work together to provide optimal team-based care. The book integrates advanced systemic therapeutics including immune-based and targeted therapies. Readers gain a better understanding of the benefit of multidisciplinary co-management through specific examples such as hormone sensitive metastatic prostate cancer, neoadjuvant chemotherapy for muscle invasive bladdercancer, and immunotherapy approaches to advanced bladder and kidney cancer. The book also discusses the integration of genomic tumor characterization and personalized medicine into surgical planning, tumor biopsies, and chemo-immunotherapy selection, emphasizing the expansion of new therapeutics for urologic malignancies and the changing definitions of disease progression.
Urologic Oncology: Multidisciplinary Care for Patients is a comprehensive resource for urologists, medical oncologists, radiation oncologists, genetic counselors, fellows in urologic oncology and medical oncology, residents in urology and radiation oncology, advanced practice providers, practice managers, and pharmaceutical representatives.
Similar content being viewed by others
Table of contents (20 chapters)
-
-
- J. Ryan Mark, Leonard G. Gomella
Pages 1-14
-
- Elizabeth Wulff-Burchfield
Pages 15-60
-
- Brittany M. Szymaniak, Lauren A. Facchini, Max F. Kelsten, Heather H. Cheng, Alicia K. Morgans
Pages 61-73
-
- Alexander P. Cole, Quoc-Dien Trinh, Adam S. Kibel
Pages 75-95
-
- Woodson W. Smelser, Christopher J. D. Wallis, Kelvin A. Moses
Pages 97-117
-
- Daniel C. Parker, Michael S. Cookson
Pages 119-129
-
- Mohammad Atiq, Ravi Madan
Pages 131-146
-
- Ali Aria Razmaria, Heiko Schoder, Michael J. Morris
Pages 147-178
-
-
- Soumyajit Roy, Daniel E. Spratt
Pages 197-213
-
- Wesley H. Chou, Daniel Lin, Viraj Master, Sarah P. Psutka
Pages 215-241
-
-
- Juan Javier-DesLoges, Ithaar Derweesh, Rana R. McKay
Pages 263-283
-
- Hong Truong, Maria I. Carlo
Pages 285-298
-
- Georgia Sofia Karachaliou, Nathan Hirshman, Tian Zhang
Pages 299-312
-
- Benjamin M. Eilender, Andrew B. Katims, John L. Pfail, John Sfakianos
Pages 313-348
-
- Brendan J. Guercio, Gopa Iyer
Pages 349-379
-
- Amishi Bajaj, Sean Sachdev
Pages 381-424
-
- Yu Fujiwara, Hirotaka Miyashita, Matthew D. Galsky
Pages 425-441
Editors and Affiliations
-
Urology, University of Oklahoma Health Science Center, Oklahoma City, USA
Kelly L. Stratton
-
Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
Alicia K. Morgans
About the editors
Kelly L. Stratton
Associate Professor
Department of Urology
University of Oklahoma Health Science Center
Oklahoma City, OK
USA
Alicia K. Morgans
Genitourinary Medical Oncologist
Medical Director, Survivorship Program
Dana-Farber Cancer Institute
Boston, MA
USA